Relmada Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
Relmada Therapeutics, Inc.
3.59
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $77.3M | 11.12% | — | |
| 2 | BlackRockBlackRockindex-like | $51.4M | 7.39% | +475.92% | |
| 3 | Squadron Capital ManagementSquadron | $50.9M | 7.32% | −13.27% | |
| 4 | VR AdviserVR Adviser | $47.4M | 6.81% | +41.31% | |
| 5 | Spruce Street CapitalSpruce Street Capital | $44.2M | 6.36% | +2.06% | |
| 6 | Adage Capital Partners GPAdage Capital Partners GP | $33.0M | 4.74% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $30.9M | 4.44% | +44.97% | |
| 8 | Jones Hill CapitalJones Hill Capital | $25.3M | 3.64% | +966.39% | |
| 9 | Orbimed AdvisorsOrbimed | $25.1M | 3.61% | −23.00% | |
| 10 | State StreetState Streetindex-like | $17.4M | 2.51% | +605.12% | |
| 11 | Geode Capital ManagementGeodeindex-like | $17.3M | 2.48% | +193.70% | |
| 12 | Millennium ManagementMillennium | $16.3M | 2.35% | −39.55% | |
| 13 | Marshall WaceMarshall Wace | $15.5M | 2.24% | −49.87% | |
| 14 | Ikarian CapitalIkarian Capital | $14.9M | 2.14% | −20.09% | |
| 15 | Driehaus Capital ManagementDriehaus | $14.8M | 2.12% | 0.00% | |
| 16 | Ameriprise FinancialAmeriprise Financial | $13.4M | 1.93% | +21.81% | |
| 17 | Eventide Asset ManagementEventide | $12.9M | 1.85% | +120.69% | |
| 18 | Balyasny Asset ManagementBalyasny | $10.5M | 1.51% | +502.36% | |
| 19 | StemPoint CapitalStemPoint Capital | $10.1M | 1.45% | +144.40% | |
| 20 | Commodore CapitalCommodore Capital | $9.9M | 1.42% | +124.80% | |
| 21 | Polar Capital HoldingsPolar Capital | $9.3M | 1.33% | −5.24% | |
| 22 | Citadel AdvisorsCitadel | $8.1M | 1.17% | +4717.55% | |
| 23 | Sio Capital ManagementSio | $6.9M | 1.00% | +4.00% | |
| 24 | Opaleye ManagementOpaleye | $6.5M | 0.93% | 0.00% | |
| 25 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $6.2M | 0.89% | new |
126 managers report $695.1M of Relmada Therapeutics on form 13F for the quarter ended Jun 30 '26. 23 of them hold 80% of it; Jupiter Topco is largest at 11.12%.
Expected move
Inputsstraddle ±27.3%
spot 3.58exp Nov 20ATM strike 2.5ATM straddle 1.15IV 71%